DNLI
Price
$14.70
Change
+$0.48 (+3.38%)
Updated
Jun 6 closing price
Capitalization
2.07B
52 days until earnings call
MLTX
Price
$46.88
Change
-$1.95 (-3.99%)
Updated
Jun 6 closing price
Capitalization
3.1B
59 days until earnings call
Interact to see
Advertisement

DNLI vs MLTX

Header iconDNLI vs MLTX Comparison
Open Charts DNLI vs MLTXBanner chart's image
Denali Therapeutics
Price$14.70
Change+$0.48 (+3.38%)
Volume$1.79M
Capitalization2.07B
MoonLake Immunotherapeutics
Price$46.88
Change-$1.95 (-3.99%)
Volume$881.42K
Capitalization3.1B
DNLI vs MLTX Comparison Chart
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNLI vs. MLTX commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Hold and MLTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (DNLI: $13.04 vs. MLTX: $38.17)
Brand notoriety: DNLI and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 82% vs. MLTX: 52%
Market capitalization -- DNLI: $2.07B vs. MLTX: $3.1B
DNLI [@Biotechnology] is valued at $2.07B. MLTX’s [@Biotechnology] market capitalization is $3.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileMLTX’s FA Score has 0 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • MLTX’s FA Score: 0 green, 5 red.
According to our system of comparison, MLTX is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 3 TA indicator(s) are bullish while MLTX’s TA Score has 3 bullish TA indicator(s).

  • DNLI’s TA Score: 3 bullish, 6 bearish.
  • MLTX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than DNLI.

Price Growth

DNLI (@Biotechnology) experienced а -4.75% price change this week, while MLTX (@Biotechnology) price change was -0.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

DNLI is expected to report earnings on Jul 31, 2025.

MLTX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($3.1B) has a higher market cap than DNLI($2.07B). MLTX YTD gains are higher at: -29.511 vs. DNLI (-36.016). MLTX has higher annual earnings (EBITDA): -141.71M vs. DNLI (-492.89M). DNLI has more cash in the bank: 832M vs. MLTX (448M). MLTX has less debt than DNLI: MLTX (2.83M) vs DNLI (48.7M). DNLI (0) and MLTX (0) have equivalent revenues.
DNLIMLTXDNLI / MLTX
Capitalization2.07B3.1B67%
EBITDA-492.89M-141.71M348%
Gain YTD-36.016-29.511122%
P/E RatioN/AN/A-
Revenue00-
Total Cash832M448M186%
Total Debt48.7M2.83M1,721%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLIMLTX
RSI
ODDS (%)
Bearish Trend 12 days ago
89%
N/A
Stochastic
ODDS (%)
Bullish Trend 12 days ago
75%
Bullish Trend 12 days ago
67%
Momentum
ODDS (%)
Bearish Trend 12 days ago
81%
Bearish Trend 12 days ago
52%
MACD
ODDS (%)
Bearish Trend 12 days ago
76%
Bearish Trend 12 days ago
58%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
83%
Bearish Trend 12 days ago
59%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
85%
Bearish Trend 12 days ago
58%
Advances
ODDS (%)
Bullish Trend 20 days ago
78%
Bullish Trend 20 days ago
81%
Declines
ODDS (%)
Bearish Trend 12 days ago
80%
Bearish Trend 12 days ago
73%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 12 days ago
69%
Bullish Trend 12 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with BEAM. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
-1.29%
BEAM - DNLI
61%
Loosely correlated
-0.88%
RCKT - DNLI
59%
Loosely correlated
+6.44%
NTLA - DNLI
59%
Loosely correlated
+3.59%
ARWR - DNLI
58%
Loosely correlated
+1.24%
RGNX - DNLI
58%
Loosely correlated
-5.84%
More

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with XENE. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
-1.06%
XENE - MLTX
46%
Loosely correlated
-3.29%
CLDX - MLTX
46%
Loosely correlated
-5.66%
DNLI - MLTX
46%
Loosely correlated
-1.29%
IDYA - MLTX
45%
Loosely correlated
+0.72%
NTLA - MLTX
45%
Loosely correlated
+3.59%
More